Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

A Randomized Trial of Zoledronic Acid to Prevent Bone Loss in the First Year after Kidney Transplantation.

Marques IDB, Araújo MJCLN, Graciolli FG, Dos Reis LM, Pereira RMR, Alvarenga JC, Custódio MR, Jorgetti V, Elias RM, Moysés RMA, David-Neto E.

J Am Soc Nephrol. 2019 Jan 3. pii: ASN.2018060656. doi: 10.1681/ASN.2018060656. [Epub ahead of print]

PMID:
30606784
2.

Integrated analysis of ethionamide resistance loci in Mycobacterium tuberculosis clinical isolates.

da Silva DA, Ferreira NV, Rego AM, Barbosa PCP, Machado RF, Pimentel A, Dos Reis LM, de Pina LC, Redner P, Caldas PCS, Fandinho-Montes FCO, Borga L, Leite SP, da Rocha JL, Bastos LS, Ramos JP, Degrave WM, Antunes LCM, Galvão TC.

Tuberculosis (Edinb). 2018 Dec;113:163-174. doi: 10.1016/j.tube.2018.08.010. Epub 2018 Aug 26.

PMID:
30514498
3.

The unexpected presence of iron in bone biopsies of hemodialysis patients.

Custodio MR, Elias RM, Velasquez WD, Dos Reis LM, Oliveira IB, Moysés RMA, Carvalho AB, Jorgetti V.

Int Urol Nephrol. 2018 Oct;50(10):1907-1912. doi: 10.1007/s11255-018-1936-4. Epub 2018 Aug 22.

PMID:
30136087
4.

A prospective study of the influence of the skeleton on calcium mass transfer during hemodialysis.

Goldenstein PT, Graciolli FG, Antunes GL, Dominguez WV, Dos Reis LM, Moe S, Elias RM, Jorgetti V, Moysés RMA.

PLoS One. 2018 Jul 30;13(7):e0198946. doi: 10.1371/journal.pone.0198946. eCollection 2018.

5.

The effect of vitamin D and zoledronic acid in bone marrow adiposity in kidney transplant patients: A post hoc analysis.

Hernandez MJ, Dos Reis LM, Marques ID, Araujo MJ, Truyts CAM, Oliveira IB, Barreto FC, David-Neto E, Custodio MR, Moyses RM, Bellorin-Font E, Jorgetti V.

PLoS One. 2018 May 25;13(5):e0197994. doi: 10.1371/journal.pone.0197994. eCollection 2018.

6.

Effect of the Auricular Acupoint Associated with Physical Exercise in Elderly People: A Randomized Clinical Test.

de Carvalho Fonseca RG, Silva AM, Teixeira LF, Silva VR, Dos Reis LM, Silva Santos AT.

J Acupunct Meridian Stud. 2018 Aug;11(4):137-144. doi: 10.1016/j.jams.2018.05.003. Epub 2018 May 16.

7.

Comparison of clinical, biochemical and histomorphometric analysis of bone biopsies in dialysis patients with and without fractures.

Santos MFP, Hernández MJ, de Oliveira IB, Siqueira FR, Dominguez WV, Dos Reis LM, Carvalho AB, Moysés RMA, Jorgetti V.

J Bone Miner Metab. 2018 Jan 25. doi: 10.1007/s00774-018-0902-7. [Epub ahead of print]

PMID:
29372334
8.

Effect of variations in dietary Pi intake on intestinal Pi transporters (NaPi-IIb, PiT-1, and PiT-2) and phosphate-regulating factors (PTH, FGF-23, and MEPE).

Aniteli TM, de Siqueira FR, Dos Reis LM, Dominguez WV, de Oliveira EMC, Castelucci P, Moysés RMA, Jorgetti V.

Pflugers Arch. 2018 Apr;470(4):623-632. doi: 10.1007/s00424-018-2111-6. Epub 2018 Jan 25.

PMID:
29372301
9.

Parathyroidectomy in patients with chronic kidney disease: Impacts of different techniques on the biochemical and clinical evolution of secondary hyperparathyroidism.

Albuquerque RFC, Carbonara CEM, Martin RCT, Dos Reis LM, do Nascimento CP Júnior, Arap SS, Moysés RMA, Jorgetti V, Montenegro FLM, de Oliveira RB.

Surgery. 2018 Feb;163(2):381-387. doi: 10.1016/j.surg.2017.09.005. Epub 2017 Nov 13.

PMID:
29146232
10.

Hypovitaminosis D in patients undergoing kidney transplant: the importance of sunlight exposure.

Vilarta CF, Unger MD, Dos Reis LM, Dominguez WV, David-Neto E, Moysés RM, Titan S, Custodio MR, Hernandez MJ, Jorgetti V.

Clinics (Sao Paulo). 2017 Jul;72(7):415-421. doi: 10.6061/clinics/2017(07)05.

11.

Renal osteodystrophy in the obesity era: Is metabolic syndrome relevant?

Da Silva Martins J, Castro JH, Sainz Rueda NA, Dos Reis LM, Jorgetti V, Affonso Moysés RM, Caramori JT.

PLoS One. 2017 Jul 18;12(7):e0180387. doi: 10.1371/journal.pone.0180387. eCollection 2017.

12.

The complexity of chronic kidney disease-mineral and bone disorder across stages of chronic kidney disease.

Graciolli FG, Neves KR, Barreto F, Barreto DV, Dos Reis LM, Canziani ME, Sabbagh Y, Carvalho AB, Jorgetti V, Elias RM, Schiavi S, Moysés RMA.

Kidney Int. 2017 Jun;91(6):1436-1446. doi: 10.1016/j.kint.2016.12.029. Epub 2017 Mar 18.

PMID:
28318623
13.

Serum levels of fibroblast growth factor 23 are elevated in patients with active Lupus nephritis.

Resende AL, Elias RM, Wolf M, Dos Reis LM, Graciolli FG, Santos GD, Dias CB, Jorgetti V, Woronik V, Moysés RM.

Cytokine. 2017 Mar;91:124-127. doi: 10.1016/j.cyto.2016.12.022. Epub 2017 Jan 4.

PMID:
28063327
14.

Predictive Factors of One-Year Mortality in a Cohort of Patients Undergoing Urgent-Start Hemodialysis.

Magalhães LP, Dos Reis LM, Graciolli FG, Pereira BJ, de Oliveira RB, de Souza AA, Moyses RM, Elias RM, Jorgetti V.

PLoS One. 2017 Jan 3;12(1):e0167895. doi: 10.1371/journal.pone.0167895. eCollection 2017.

15.

Histomorphometric bone assessment in patients with fracture of the proximal end of the femur.

de Souza CG, de Souza MP, Jorgetti V, Dos Reis LM.

Acta Ortop Bras. 2015 Mar-Apr;23(2):103-6. doi: 10.1590/1413-78522015230201056.

16.

Histomorphometric analysis of the femoral neck in patients with and without femoral neck fracture.

de Souza CG, Jorgetti V, Dos Reis LM, Croci AT.

Acta Ortop Bras. 2015 Mar-Apr;23(2):98-102. doi: 10.1590/1413-78522015230201055.

17.

Can we compare serum sclerostin results obtained with different assays in hemodialysis patients?

Moysés RM, Jamal SA, Graciolli FG, dos Reis LM, Elias RM.

Int Urol Nephrol. 2015 May;47(5):847-50. doi: 10.1007/s11255-015-0971-7. Epub 2015 Apr 11.

PMID:
25862239
18.

Peritoneal dialysis per se is a risk factor for sclerostin-associated adynamic bone disease.

de Oliveira RA, Barreto FC, Mendes M, dos Reis LM, Castro JH, Britto ZM, Marques ID, Carvalho AB, Moysés RM, Jorgetti V.

Kidney Int. 2015 May;87(5):1039-45. doi: 10.1038/ki.2014.372. Epub 2014 Dec 10.

PMID:
25493951
19.

Serum sclerostin is an independent predictor of mortality in hemodialysis patients.

Gonçalves FL, Elias RM, dos Reis LM, Graciolli FG, Zampieri FG, Oliveira RB, Jorgetti V, Moysés RM.

BMC Nephrol. 2014 Dec 2;15:190. doi: 10.1186/1471-2369-15-190.

20.

Correction of metabolic acidosis in hemodialysis: consequences on serum leptin and mineral metabolism.

Bales AM, Moysés RM, dos Reis LM, Graciolli FG, Hung J, Martins Castro MC, Elias RM.

Int Urol Nephrol. 2015 Jan;47(1):177-82. doi: 10.1007/s11255-014-0844-5. Epub 2014 Sep 25.

PMID:
25252843
21.

Bone disease in newly diagnosed lupus nephritis patients.

Resende AL, dos Reis LM, Dias CB, Custódio MR, Jorgetti V, Woronik V.

PLoS One. 2014 Sep 17;9(9):e106728. doi: 10.1371/journal.pone.0106728. eCollection 2014.

22.

Mineral bone disorder in chronic kidney disease: head-to-head comparison of the 5/6 nephrectomy and adenine models.

Ferrari GO, Ferreira JC, Cavallari RT, Neves KR, dos Reis LM, Dominguez WV, Oliveira EC, Graciolli FG, Passlick-Deetjen J, Jorgetti V, Moysés RM.

BMC Nephrol. 2014 May 3;15:69. doi: 10.1186/1471-2369-15-69.

23.

Description of a new Mycobacterium intracellulare pattern of PCR restriction enzyme analysis of hsp65 gene.

Caldas PC, Campos CE, Dos Reis LM, Ferreira NV, de Carvalho LD, da Silva MV, Medeiros RF, Montes FC, Ramos JP.

Diagn Microbiol Infect Dis. 2014 Jun;79(2):240-1. doi: 10.1016/j.diagmicrobio.2014.01.028. Epub 2014 Feb 20.

PMID:
24655570
24.

Ethnic differences in bone and mineral metabolism in healthy people and patients with CKD.

Jorgetti V, dos Reis LM, Ott SM.

Kidney Int. 2014 Jun;85(6):1283-9. doi: 10.1038/ki.2013.443. Epub 2013 Dec 18. Review.

25.

Effects of dietary phosphate on adynamic bone disease in rats with chronic kidney disease--role of sclerostin?

Ferreira JC, Ferrari GO, Neves KR, Cavallari RT, Dominguez WV, Dos Reis LM, Graciolli FG, Oliveira EC, Liu S, Sabbagh Y, Jorgetti V, Schiavi S, Moysés RM.

PLoS One. 2013 Nov 13;8(11):e79721. doi: 10.1371/journal.pone.0079721. eCollection 2013.

26.

Prefabricated bone flap: an experimental study comparing deep-frozen and lyophilized-demineralized allogenic bones and tissue expression of transforming growth factor β.

Rodrigues L, dos Reis LM, Denadai R, Raposo-Amaral CE, Alonso N, Ferreira MC, Jorgetti V.

J Craniofac Surg. 2013 Nov;24(6):1914-21. doi: 10.1097/SCS.0b013e3182a41be2.

PMID:
24220373
27.

Disturbances of Wnt/β-catenin pathway and energy metabolism in early CKD: effect of phosphate binders.

de Oliveira RB, Graciolli FG, dos Reis LM, Cancela AL, Cuppari L, Canziani ME, Carvalho AB, Jorgetti V, Moysés RM.

Nephrol Dial Transplant. 2013 Oct;28(10):2510-7. doi: 10.1093/ndt/gft234. Epub 2013 Aug 23.

PMID:
23975746
28.

Persistence of bone and mineral disorders 2 years after successful kidney transplantation.

Neves CL, dos Reis LM, Batista DG, Custodio MR, Graciolli FG, Martin Rde C, Neves KR, Dominguez WV, Moyses RM, Jorgetti V.

Transplantation. 2013 Aug 15;96(3):290-6. doi: 10.1097/TP.0b013e3182985468.

PMID:
23823648
29.

Bone plasticity in response to exercise is sex-dependent in rats.

Vicente WS, dos Reis LM, Graciolli RG, Graciolli FG, Dominguez WV, Wang CC, Fonseca TL, Velosa AP, Roschel H, Teodoro WR, Gualano B, Jorgetti V.

PLoS One. 2013 May 31;8(5):e64725. doi: 10.1371/journal.pone.0064725. Print 2013.

30.

Phosphorus is associated with coronary artery disease in patients with preserved renal function.

Cancela AL, Santos RD, Titan SM, Goldenstein PT, Rochitte CE, Lemos PA, dos Reis LM, Graciolli FG, Jorgetti V, Moysés RM.

PLoS One. 2012;7(5):e36883. doi: 10.1371/journal.pone.0036883. Epub 2012 May 10.

31.

Repression of osteocyte Wnt/β-catenin signaling is an early event in the progression of renal osteodystrophy.

Sabbagh Y, Graciolli FG, O'Brien S, Tang W, dos Reis LM, Ryan S, Phillips L, Boulanger J, Song W, Bracken C, Liu S, Ledbetter S, Dechow P, Canziani ME, Carvalho AB, Jorgetti V, Moyses RM, Schiavi SC.

J Bone Miner Res. 2012 Aug;27(8):1757-72. doi: 10.1002/jbmr.1630.

32.

Parathyroid hormone and phosphorus overload in uremia: impact on cardiovascular system.

Custódio MR, Koike MK, Neves KR, dos Reis LM, Graciolli FG, Neves CL, Batista DG, Magalhães AO, Hawlitschek P, Oliveira IB, Dominguez WV, Moysés RM, Jorgetti V.

Nephrol Dial Transplant. 2012 Apr;27(4):1437-45. doi: 10.1093/ndt/gfr447. Epub 2011 Aug 8.

PMID:
21825304
33.

FGF-23 as a predictor of renal outcome in diabetic nephropathy.

Titan SM, Zatz R, Graciolli FG, dos Reis LM, Barros RT, Jorgetti V, Moysés RM.

Clin J Am Soc Nephrol. 2011 Feb;6(2):241-7. doi: 10.2215/CJN.04250510. Epub 2010 Oct 21.

34.

Fibroblast growth factor 23 in hemodialysis patients: effects of phosphate binder, calcitriol and calcium concentration in the dialysate.

Cancela AL, Oliveira RB, Graciolli FG, dos Reis LM, Barreto F, Barreto DV, Cuppari L, Jorgetti V, Carvalho AB, Canziani ME, Moysés RM.

Nephron Clin Pract. 2011;117(1):c74-82. doi: 10.1159/000319650. Epub 2010 Aug 4.

PMID:
20689328
35.

Vitamin D status in a sunny country: where has the sun gone?

Unger MD, Cuppari L, Titan SM, Magalhães MC, Sassaki AL, dos Reis LM, Jorgetti V, Moysés RM.

Clin Nutr. 2010 Dec;29(6):784-8. doi: 10.1016/j.clnu.2010.06.009. Epub 2010 Jul 15.

PMID:
20637530
36.

Skeletal microstructural abnormalities in postmenopausal women with chronic obstructive pulmonary disease.

Kulak CA, Borba VC, Jorgetti V, Dos Reis LM, Liu XS, Kimmel DB, Kulak J Jr, Rabelo LM, Zhou H, Guo XE, Bilezikian JP, Boguszewski CL, Dempster DW.

J Bone Miner Res. 2010 Sep;25(9):1931-40. doi: 10.1002/jbmr.88.

37.

The bone histology spectrum in experimental renal failure: adverse effects of phosphate and parathyroid hormone disturbances.

Batista DG, Neves KR, Graciolli FG, dos Reis LM, Graciolli RG, Dominguez WV, Neves CL, Magalhães AO, Custódio MR, Moysés RM, Jorgetti V.

Calcif Tissue Int. 2010 Jul;87(1):60-7. doi: 10.1007/s00223-010-9367-y. Epub 2010 Apr 29.

PMID:
20428857
38.

Chronic kidney disease bone and mineral disorder (CKD-MBD) in apolipoprotein E-deficient mice with chronic renal failure.

Nikolov IG, Joki N, Nguyen-Khoa T, Ivanovski O, Phan O, Lacour B, Drüeke TB, Massy ZA, Dos Reis LM, Jorgetti V, Lafage-Proust MH.

Bone. 2010 Jul;47(1):156-63. doi: 10.1016/j.bone.2010.04.600. Epub 2010 Apr 18.

PMID:
20406703
39.

Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy?

Oliveira RB, Cancela AL, Graciolli FG, Dos Reis LM, Draibe SA, Cuppari L, Carvalho AB, Jorgetti V, Canziani ME, Moysés RM.

Clin J Am Soc Nephrol. 2010 Feb;5(2):286-91. doi: 10.2215/CJN.05420709. Epub 2009 Nov 12.

40.

Etiopathogenesis of hepatic osteodystrophy in Wistar rats with cholestatic liver disease.

Pereira FA, Facincani I, Jorgetti V, Ramalho LN, Volpon JB, Dos Reis LM, de Paula FJ.

Calcif Tissue Int. 2009 Jul;85(1):75-83. doi: 10.1007/s00223-009-9249-3. Epub 2009 May 8.

PMID:
19424739
41.

Phosphorus overload and PTH induce aortic expression of Runx2 in experimental uraemia.

Graciolli FG, Neves KR, dos Reis LM, Graciolli RG, Noronha IL, Moysés RM, Jorgetti V.

Nephrol Dial Transplant. 2009 May;24(5):1416-21. doi: 10.1093/ndt/gfn686. Epub 2008 Dec 15.

PMID:
19075196
42.

Intra-periaqueductal gray matter injections of midazolam fail to alter anxiety in plus-maze experienced mice.

dos Reis LM, Canto-de-Souza A.

Brain Res. 2008 Sep 22;1231:93-102. doi: 10.1016/j.brainres.2008.06.042. Epub 2008 Jun 21.

PMID:
18621039
43.

RANKL is a mediator of bone resorption in idiopathic hypercalciuria.

Gomes SA, dos Reis LM, Noronha IL, Jorgetti V, Heilberg IP.

Clin J Am Soc Nephrol. 2008 Sep;3(5):1446-52. doi: 10.2215/CJN.00240108. Epub 2008 May 14.

44.

Usefulness of a quick decalcification of bone sections embedded in methyl methacrylate[corrected]: an improved method for immunohistochemistry.

Gomes SA, dos Reis LM, de Oliveira IB, Noronha IL, Jorgetti V, Heilberg IP.

J Bone Miner Metab. 2008;26(1):110-3. Epub 2008 Jan 10.

PMID:
18095073
45.

Brazilian normal static bone histomorphometry: effects of age, sex, and race.

Dos Reis LM, Batalha JR, Muñoz DR, Borelli A, Correa PH, Carvalho AB, Jorgetti V.

J Bone Miner Metab. 2007;25(6):400-6. Epub 2007 Oct 25.

PMID:
17968492
46.

Vascular calcification: contribution of parathyroid hormone in renal failure.

Neves KR, Graciolli FG, dos Reis LM, Graciolli RG, Neves CL, Magalhães AO, Custódio MR, Batista DG, Jorgetti V, Moysés RM.

Kidney Int. 2007 Jun;71(12):1262-70. Epub 2007 Apr 4.

47.

Decreased in vitro osteoblast proliferation and low turnover bone disease in nonuremic proteinuric patients.

Dias CB, Dos Reis LM, Caparbo VF, Graciolli FG, Moysés RM, Barros RT, Jorgetti V, Woronik V.

Kidney Int. 2007 Mar;71(6):562-8. Epub 2007 Jan 17.

48.

Variant of adynamic bone disease in hemodialysis patients: fact or fiction?

Rocha LA, Higa A, Barreto FC, dos Reis LM, Jorgetti V, Draibe SA, Carvalho AB.

Am J Kidney Dis. 2006 Sep;48(3):430-6.

PMID:
16931216
49.

Topology-dependent protein folding rates analyzed by a stereochemical model.

Silva IR, Dos Reis LM, Caliri A.

J Chem Phys. 2005 Oct 15;123(15):154906.

PMID:
16252971
50.

MIBI scintigraphy, indicators of cell proliferation and histology of parathyroid glands in uraemic patients.

Custódio MR, Montenegro F, Costa AF, dos Reis LM, Buchpiguel CA, Oliveira SG, Noronha IL, Moysés RM, Jorgetti V.

Nephrol Dial Transplant. 2005 Sep;20(9):1898-903. Epub 2005 Jun 14.

PMID:
15956063

Supplemental Content

Loading ...
Support Center